Long-term safety and effectiveness of the "optease" vena cava filter

Sanjeeva P. Kalva, Theodore C. Marentis, Kalpana Yeddula, Bhanusupriya Somarouthu, Stephan Wicky, Michael S. Stecker

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: To assess the long-term safety and effectiveness of the OptEase inferior vena cava (IVC) filter. Materials and Methods: In this Institutional Review Board-approved, retrospective study, we reviewed data of 71 patients who received an OptEase filter at our institution from 2002 to 2007. Thirty-nine (55%) patients had symptoms of venous thromboembolism before filter placement. The indications for filter included contraindication to anticoagulation in 31 (44%) patients, prophylaxis against pulmonary embolism (PE) in 29 (41%) patients, and failure of anticoagulation in 11 (15%) patients. Procedure-related complications, such as symptomatic post-filter PE, deep venous thrombosis (DVT), IVC occlusion, and incidental imaging-evident filter-related complications, were recorded. Safety was assessed by the occurrence of filter-related complications during placement and follow-up. Effectiveness was assessed by the occurrence of post-filter PE. Results: Sixty-five (92%) filters were placed under fluoroscopy, and 6 (8%) were placed using intravascular ultrasound guidance. Seventy (99%) filters were placed successfully. Seven (10%) filters were placed in the suprarenal cava. Retrieval was attempted in 14 (20%) patients, and 12 filters were successfully retrieved. Clinical follow-up was available for 20 ± 21 months. Symptoms of postfilter PE and DVT occurred in 15% (n = 11) and 10% (n = 7) patients, respectively. None of these patients had computed tomography (CT)-proven PE, and only one had ultrasound-proven new DVT. One patient had symptomatic IVC occlusion. Follow-up abdominal CT in 20 patients showed thrombus in the filter in two of them. There were no instances of filter migration, filter tilt, or caval wall penetration. Conclusion: The OptEase filter appears to have an acceptable long-term safety profile. The filter was effective against PE.

Original languageEnglish (US)
Pages (from-to)331-337
Number of pages7
JournalCardioVascular and Interventional Radiology
Volume34
Issue number2
DOIs
StatePublished - Apr 2011

Fingerprint

Vena Cava Filters
Safety
Pulmonary Embolism
Venous Thrombosis
Inferior Vena Cava
Tomography
Venae Cavae
Research Ethics Committees
Fluoroscopy
Venous Thromboembolism
Thrombosis
Retrospective Studies

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Kalva, S. P., Marentis, T. C., Yeddula, K., Somarouthu, B., Wicky, S., & Stecker, M. S. (2011). Long-term safety and effectiveness of the "optease" vena cava filter. CardioVascular and Interventional Radiology, 34(2), 331-337. https://doi.org/10.1007/s00270-010-9969-9

Long-term safety and effectiveness of the "optease" vena cava filter. / Kalva, Sanjeeva P.; Marentis, Theodore C.; Yeddula, Kalpana; Somarouthu, Bhanusupriya; Wicky, Stephan; Stecker, Michael S.

In: CardioVascular and Interventional Radiology, Vol. 34, No. 2, 04.2011, p. 331-337.

Research output: Contribution to journalArticle

Kalva, SP, Marentis, TC, Yeddula, K, Somarouthu, B, Wicky, S & Stecker, MS 2011, 'Long-term safety and effectiveness of the "optease" vena cava filter', CardioVascular and Interventional Radiology, vol. 34, no. 2, pp. 331-337. https://doi.org/10.1007/s00270-010-9969-9
Kalva, Sanjeeva P. ; Marentis, Theodore C. ; Yeddula, Kalpana ; Somarouthu, Bhanusupriya ; Wicky, Stephan ; Stecker, Michael S. / Long-term safety and effectiveness of the "optease" vena cava filter. In: CardioVascular and Interventional Radiology. 2011 ; Vol. 34, No. 2. pp. 331-337.
@article{0237223b42f74d4599e41c178043be72,
title = "Long-term safety and effectiveness of the {"}optease{"} vena cava filter",
abstract = "Purpose: To assess the long-term safety and effectiveness of the OptEase inferior vena cava (IVC) filter. Materials and Methods: In this Institutional Review Board-approved, retrospective study, we reviewed data of 71 patients who received an OptEase filter at our institution from 2002 to 2007. Thirty-nine (55{\%}) patients had symptoms of venous thromboembolism before filter placement. The indications for filter included contraindication to anticoagulation in 31 (44{\%}) patients, prophylaxis against pulmonary embolism (PE) in 29 (41{\%}) patients, and failure of anticoagulation in 11 (15{\%}) patients. Procedure-related complications, such as symptomatic post-filter PE, deep venous thrombosis (DVT), IVC occlusion, and incidental imaging-evident filter-related complications, were recorded. Safety was assessed by the occurrence of filter-related complications during placement and follow-up. Effectiveness was assessed by the occurrence of post-filter PE. Results: Sixty-five (92{\%}) filters were placed under fluoroscopy, and 6 (8{\%}) were placed using intravascular ultrasound guidance. Seventy (99{\%}) filters were placed successfully. Seven (10{\%}) filters were placed in the suprarenal cava. Retrieval was attempted in 14 (20{\%}) patients, and 12 filters were successfully retrieved. Clinical follow-up was available for 20 ± 21 months. Symptoms of postfilter PE and DVT occurred in 15{\%} (n = 11) and 10{\%} (n = 7) patients, respectively. None of these patients had computed tomography (CT)-proven PE, and only one had ultrasound-proven new DVT. One patient had symptomatic IVC occlusion. Follow-up abdominal CT in 20 patients showed thrombus in the filter in two of them. There were no instances of filter migration, filter tilt, or caval wall penetration. Conclusion: The OptEase filter appears to have an acceptable long-term safety profile. The filter was effective against PE.",
author = "Kalva, {Sanjeeva P.} and Marentis, {Theodore C.} and Kalpana Yeddula and Bhanusupriya Somarouthu and Stephan Wicky and Stecker, {Michael S.}",
year = "2011",
month = "4",
doi = "10.1007/s00270-010-9969-9",
language = "English (US)",
volume = "34",
pages = "331--337",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Long-term safety and effectiveness of the "optease" vena cava filter

AU - Kalva, Sanjeeva P.

AU - Marentis, Theodore C.

AU - Yeddula, Kalpana

AU - Somarouthu, Bhanusupriya

AU - Wicky, Stephan

AU - Stecker, Michael S.

PY - 2011/4

Y1 - 2011/4

N2 - Purpose: To assess the long-term safety and effectiveness of the OptEase inferior vena cava (IVC) filter. Materials and Methods: In this Institutional Review Board-approved, retrospective study, we reviewed data of 71 patients who received an OptEase filter at our institution from 2002 to 2007. Thirty-nine (55%) patients had symptoms of venous thromboembolism before filter placement. The indications for filter included contraindication to anticoagulation in 31 (44%) patients, prophylaxis against pulmonary embolism (PE) in 29 (41%) patients, and failure of anticoagulation in 11 (15%) patients. Procedure-related complications, such as symptomatic post-filter PE, deep venous thrombosis (DVT), IVC occlusion, and incidental imaging-evident filter-related complications, were recorded. Safety was assessed by the occurrence of filter-related complications during placement and follow-up. Effectiveness was assessed by the occurrence of post-filter PE. Results: Sixty-five (92%) filters were placed under fluoroscopy, and 6 (8%) were placed using intravascular ultrasound guidance. Seventy (99%) filters were placed successfully. Seven (10%) filters were placed in the suprarenal cava. Retrieval was attempted in 14 (20%) patients, and 12 filters were successfully retrieved. Clinical follow-up was available for 20 ± 21 months. Symptoms of postfilter PE and DVT occurred in 15% (n = 11) and 10% (n = 7) patients, respectively. None of these patients had computed tomography (CT)-proven PE, and only one had ultrasound-proven new DVT. One patient had symptomatic IVC occlusion. Follow-up abdominal CT in 20 patients showed thrombus in the filter in two of them. There were no instances of filter migration, filter tilt, or caval wall penetration. Conclusion: The OptEase filter appears to have an acceptable long-term safety profile. The filter was effective against PE.

AB - Purpose: To assess the long-term safety and effectiveness of the OptEase inferior vena cava (IVC) filter. Materials and Methods: In this Institutional Review Board-approved, retrospective study, we reviewed data of 71 patients who received an OptEase filter at our institution from 2002 to 2007. Thirty-nine (55%) patients had symptoms of venous thromboembolism before filter placement. The indications for filter included contraindication to anticoagulation in 31 (44%) patients, prophylaxis against pulmonary embolism (PE) in 29 (41%) patients, and failure of anticoagulation in 11 (15%) patients. Procedure-related complications, such as symptomatic post-filter PE, deep venous thrombosis (DVT), IVC occlusion, and incidental imaging-evident filter-related complications, were recorded. Safety was assessed by the occurrence of filter-related complications during placement and follow-up. Effectiveness was assessed by the occurrence of post-filter PE. Results: Sixty-five (92%) filters were placed under fluoroscopy, and 6 (8%) were placed using intravascular ultrasound guidance. Seventy (99%) filters were placed successfully. Seven (10%) filters were placed in the suprarenal cava. Retrieval was attempted in 14 (20%) patients, and 12 filters were successfully retrieved. Clinical follow-up was available for 20 ± 21 months. Symptoms of postfilter PE and DVT occurred in 15% (n = 11) and 10% (n = 7) patients, respectively. None of these patients had computed tomography (CT)-proven PE, and only one had ultrasound-proven new DVT. One patient had symptomatic IVC occlusion. Follow-up abdominal CT in 20 patients showed thrombus in the filter in two of them. There were no instances of filter migration, filter tilt, or caval wall penetration. Conclusion: The OptEase filter appears to have an acceptable long-term safety profile. The filter was effective against PE.

UR - http://www.scopus.com/inward/record.url?scp=79955552045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955552045&partnerID=8YFLogxK

U2 - 10.1007/s00270-010-9969-9

DO - 10.1007/s00270-010-9969-9

M3 - Article

C2 - 20820780

AN - SCOPUS:79955552045

VL - 34

SP - 331

EP - 337

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

IS - 2

ER -